logo
ENTITY
Hyphens Pharma International

Hyphens Pharma International (HYP SP)

30
Analysis
Health Care • Singapore
Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. Please visit us at https://www.hyphensgroup.com for more information.
more
• 15 May 2020 10:09

联合早报 - 修读课程突破思维业者自我创新“药”走向国际

• 15 May 2020 10:14

The New Paper - Innovation key to help companies expand: Koh Poh Koon

• 15 May 2020 10:22

联合早报 - 凯帆药剂新总部开幕 许宝琨：本地公司须持续创新建立竞争优势

• 15 May 2020 10:43

RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks

• 15 May 2020 10:48

Investor-One - Hyphens Pharma: A scalable business that rides on regional megatrends

• 15 May 2020 10:28

RHB's 2019 Top Singapore Small Cap Companies (9th Edition)

• 15 May 2020 10:21

The Business Times - Hyphens inks MOU with A*Star's A*ccelerate

• 15 May 2020 10:19

The Straits Times – Innovate for global competitive edge, says Koh Poh Koon

• 15 May 2020 10:12

Channel News Asia - New products in the works for common skin problems | Video

• 15 May 2020 10:51

The Straits Times - Aiming to be Asia's No. 1 skin-health firm

• 15 May 2020 10:45

Hyphens Pharma's CEO Lim See Wah tells us about Hyphens's presence and growth prospects in the region

• 02 Sep 2020 15:00

Hyphens Pharma: 5 things I like about the company

• 02 Sep 2020 15:04

Hyphens Pharma International Ltd (SGX: 1J5) - Uncovering Healthcare Gems

• 02 Sep 2020 15:06

Hyphens Pharma: Is this pharma company undervalued?

• 02 Sep 2020 15:08

Hyphens Pharma revs up digital push amid Covid-19

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.4

x